HSP70B-NIS-MSCs, 131I and hyperthermia (41 °C) treatment resulted in a robust and significant therapeutic effect with reduced tumor growth in 67% of the animals, and a partial tumor remission in one animal. This evidence concerns the gene SLC5A5 and neoplasm.